ResMed Inc. (RMD) Stock Score, Valuation & Financial Research
ResMed Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 63/100.
Quick answer for RMD
ResMed Inc. currently has a Wall Street Score of 63/100. The stored market price is $218.27. Its financial score is 43/100. Its valuation score is 68/100. These figures are a research snapshot, not a buy or sell recommendation.
What ResMed Inc. does
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with educ
RMD financial snapshot
- Wall Street Score:
- 63/100
- Current price:
- $218.27
- Market capitalization:
- $31.66B
- Revenue:
- $5.54B
- Net income:
- $1.52B
- Free cash flow:
- $1.66B
- Cash:
- $1.66B
- Total debt:
- $843.2M
- EPS:
- 9.55
- P/E ratio:
- 22.9x
- Financial score:
- 43/100
- Valuation score:
- 68/100
- Revenue score:
- 34/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $1.66B, showing positive cash generation.
- The balance sheet shows $1.66B of cash versus $843.2M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 68/100, which Wall Street Score classifies as mixed within the model's valuation framework.
The financial score is 43/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research RMD
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.